These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29140459)

  • 21. RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of Amyotrophic lateral sclerosis.
    Colombrita C; Onesto E; Tiloca C; Ticozzi N; Silani V; Ratti A
    Arch Ital Biol; 2011 Mar; 149(1):83-99. PubMed ID: 21412718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
    Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
    Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.
    Wang T; Jiang X; Chen G; Xu J
    Neurobiol Aging; 2015 Jan; 36(1):527-35. PubMed ID: 25192599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging.
    Japtok J; Lojewski X; Naumann M; Klingenstein M; Reinhardt P; Sterneckert J; Putz S; Demestre M; Boeckers TM; Ludolph AC; Liebau S; Storch A; Hermann A
    Neurobiol Dis; 2015 Oct; 82():420-429. PubMed ID: 26253605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.
    Rulten SL; Rotheray A; Green RL; Grundy GJ; Moore DA; Gómez-Herreros F; Hafezparast M; Caldecott KW
    Nucleic Acids Res; 2014 Jan; 42(1):307-14. PubMed ID: 24049082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ALS mutations in TLS/FUS disrupt target gene expression.
    Coady TH; Manley JL
    Genes Dev; 2015 Aug; 29(16):1696-706. PubMed ID: 26251528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RBM45 associates with nuclear stress bodies and forms nuclear inclusions during chronic cellular stress and in neurodegenerative diseases.
    Collins M; Li Y; Bowser R
    Acta Neuropathol Commun; 2020 Jun; 8(1):91. PubMed ID: 32586379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS).
    Nihei Y; Ito D; Suzuki N
    J Biol Chem; 2012 Nov; 287(49):41310-23. PubMed ID: 23048034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hnRNP RALY regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.
    Gasperini L; Rossi A; Cornella N; Peroni D; Zuccotti P; Potrich V; Quattrone A; Macchi P
    Mol Biol Cell; 2018 Dec; 29(26):3067-3081. PubMed ID: 30354839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.
    Mitra J; Guerrero EN; Hegde PM; Liachko NF; Wang H; Vasquez V; Gao J; Pandey A; Taylor JP; Kraemer BC; Wu P; Boldogh I; Garruto RM; Mitra S; Rao KS; Hegde ML
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4696-4705. PubMed ID: 30770445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
    Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
    J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
    Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
    Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
    Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
    Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
    Baloh RH
    Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress.
    Jun MH; Ryu HH; Jun YW; Liu T; Li Y; Lim CS; Lee YS; Kaang BK; Jang DJ; Lee JA
    Sci Rep; 2017 Jan; 7():40474. PubMed ID: 28094300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
    Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
    Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis.
    Lim SM; Choi WJ; Oh KW; Xue Y; Choi JY; Kim SH; Nahm M; Kim YE; Lee J; Noh MY; Lee S; Hwang S; Ki CS; Fu XD; Kim SH
    Mol Neurodegener; 2016 Jan; 11():8. PubMed ID: 26795035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
    Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis.
    Wang H; Guo W; Mitra J; Hegde PM; Vandoorne T; Eckelmann BJ; Mitra S; Tomkinson AE; Van Den Bosch L; Hegde ML
    Nat Commun; 2018 Sep; 9(1):3683. PubMed ID: 30206235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
    Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
    Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.